Donald Elliot Ingber

This inventor holds 119 USPTO granted patents and 95 published patent applications, plus 6 CIPO patents and 33 EPO patents, primarily in Microfluidic Devices (CPC class C12M23-16). Top assignees: Harvard College, Children's Medical Center Corporation, Massachusetts Institute of Technology. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Elliot Ingber. Retrieved from https://idiyas.com/inventor/donald-elliot-ingber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 119 (Patent Applications = 95)

% Patents Active = 90.8

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 33 (Patent Applications = 59)

Average Co-Inventor Count = 4.2

ph-index = 19

Forward Citations = 2,132(Granted Patents)

Forward Citations (Not Self Cited) = 1,997(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

Children's Medical Center Corporation

patents

5 out of 8,594

Massachusetts Institute of Technology

Takeda Chemical Industries, Inc.

patents

6. 2 out of 1,155

The Charles Stark Draper Laboratory, Inc.

patents

7. 2 out of 3,076

The General Hospital Corporation

patents

8. 1 out of 6

President and Fellows of Havard College

patents

9. 1 out of 1,429

The Brigham and Women's Hospital, Inc.

Vanderbilt University

patents

12. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2026

Loading Chart...

Areas of Expertise:

Microfluidic Devices

Organ-On-A-Chip

Antimicrobial Assays

Tissue Simulation

Cell Culture

Human Gut Microbiome

Bone Marrow Devices

Pluripotent Stem Cells

Pathogen Detection

Fluidic Interconnection

Heme-Binding Compositions

CRP Capture

119 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12553892 - Assays for antimicrobial activity and applications thereof (2026-02-17),

2. 12325846 - Open-top microfluidic devices and methods for simulating a function of a tissue (2025-06-10),

3. 12247227 - Methods relating to intestinal organ-on-a-chip (2025-03-11),

4. 12187997 - Integrated human organ-on-chip microphysiological systems (2025-01-07),

5. 12187996 - Open-top microfluidic devices and methods for simulating a function of a tissue (2025-01-07),

6. 12180447 - Bone marrow microfluidic devices and methods for preparing and using the same (2024-12-31),

7. 12173263 - Organomimetic devices and methods of use and manufacturing thereof (2024-12-24),

8. 12104174 - Methods relating to intestinal organ-on-a-chip (2024-10-01),

9. 12065634 - Systems and methods for cell culture device interconnection and fluidic device interconnection (2024-08-20),

10. 11980641 - Methods for generation of podocytes from pluripotent stem cells and cells produced by the same (2024-05-14),

11. 11976304 - Methods relating to intestinal organ-on-a-chip (2024-05-07),

12. 11940441 - Low shear microfluidic devices and methods of use and manufacturing thereof (2024-03-26),

13. 11939608 - Engineered heme-binding compositions and uses thereof (2024-03-26),

14. 11919971 - Aqueous biomolecule coupling on CO2-plasma-activated surfaces (2024-03-05),

15. 11884938 - Cell culture system (2024-01-30),

Title: The Innovations of Donald Elliot Ingber: Pioneering Scientific Breakthroughs in Boston

Introduction: Donald Elliot Ingber is a distinguished inventor based in Boston, MA, with an impressive track record of 110 patents to his name. His groundbreaking work spans various fields, contributing significantly to the realm of biomedical research and cellular engineering.

Latest Patents: Among his recent patents, Ingber has introduced novel methods for the generation of podocytes from pluripotent stem cells. These innovative techniques offer insights into creating podocytes, vital for kidney function, from versatile pluripotent stem cells. Additionally, his work on intestinal organ-on-a-chip technology demonstrates advancements in modeling complex biological systems using primary cells for enhanced accuracy and reliability.

Career Highlights: Ingber has held pivotal roles in prestigious institutions such as the President and Fellows of Harvard College and the Children's Medical Center Corporation. Through his leadership and expertise, he has spearheaded numerous research initiatives that have redefined the boundaries of biomedical engineering and regenerative medicine.

Collaborations: Collaboration plays a crucial role in Ingber's success, with notable coworkers including Michael Super and Alexander L. Watters. Together, they have combined their diverse skill sets to drive innovation, foster creativity, and ultimately transform scientific concepts into tangible solutions.

Conclusion: Donald Elliot Ingber stands as a trailblazer in the field of biomedical innovation, with a remarkable portfolio of patents that reflect his unwavering commitment to advancing scientific knowledge and improving healthcare outcomes. His pioneering contributions continue to inspire and shape the future of cellular research, making him a revered figure in the scientific community.

Profile summary based on public USPTO records.